MedPath

Screening for GDM in Women With PCOS and Controls

Not Applicable
Completed
Conditions
Polycystic Ovary Syndrome
Gestational Diabetes Mellitus
Interventions
Other: OGTT by randomization
Other: OGTT by indication
Registration Number
NCT02183558
Lead Sponsor
Odense University Hospital
Brief Summary

Women with polycystic ovary syndrome (PCOS) are often insulin resistant. During pregnancy, insulin sensitivity decreases. The investigators examine glucose metabolism during oral glucose tolerance test and the incidense of gestational diabetes mellitus in a prospective cohort of pregnant women with PCOS and controls.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
2500
Inclusion Criteria
  • Pregnancy achieved during 2010-2012
  • Residents of the municipality of Odense
Read More
Exclusion Criteria
  • Moving from Odense during pregnancy
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
OGTT by randomizationOGTT by randomizationWomen without risk factors for GDM are offered OGTT in gestational week 28
OGTT by indicationOGTT by indicationWomen with risk factors for OGTT are offered diagnostic 2 hour OGTT in pregnancy week 28
Primary Outcome Measures
NameTimeMethod
Gestational Diabetes MellitusGestational week 28

Gestational diabetes mellitus is diagnosed by 2 hour 75 gram oral glucose tolerance test in gestational week 28

Gestational diabetes mellitus2 years

Gestational diabetes mellitus diagnosed by oral glucose tolerance test in gestational week 28 in women with and without risk factors for gestational diabetes mellitus.

Secondary Outcome Measures
NameTimeMethod
Anthropometric measures in offspringAt birth

The association between blood glucose values and anthropometric measures (birth length, weight and abdominal circumference) at birth in the offspring is investigated

Trial Locations

Locations (1)

OdenseUH

🇩🇰

Odense, Denmark

© Copyright 2025. All Rights Reserved by MedPath